Cinnamon: Not suitable for the treatment of diabetes mellitus;Kaneel: Niet geschikt als behandeling voor diabetes mellitus

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 51, 2007, Pages 2833-2837

  Kleejstra, N ^a   Loatenberrj, S J J ^a   Houweling, S T ^b   Verhoeuen, S ^b   Bilo, H J G ^a  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CINNAMON EXTRACT; GLUCOSE; HEMOGLOBIN A1C; PLACEBO;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; NONHUMAN;

ANIMALS; BLOOD GLUCOSE; CINNAMOMUM ZEYLANICUM; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 37549058835     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215-8.
2. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989;12:553-64.
3. Sidney W. Mintz, sweetness and power. The place of sugar in modern history. New York: Viking; 1985.
4. Klein RM. The green world. An introduction to plants and people. New York: Harper and Row; 1979.
5. Adams J. Principals and agents, colonialists and company men: the decay of colonial control in the Dutch East Indies. Am Soc Rev. 1996;61:12-28.
6. Wijesekera RO. Historical overview of the cinnamon industry. CRC Crit Rev Food Sci Nutr. 1978;10:1-30.
7. Jarvill-Taylor KJ, Anderson RA, Graves DJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr. 2001;20:327-36.
8. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, Anderson RA, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998;50:177-82.
9. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract. 2003;62:139-48.
10. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65-70.
11. Kim SH, Hyun SH, Choung SY. Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice. Biofactors. 2006;26:209-19.
12. Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007;459:214-22.
13. Roffey B, Atwal A, Kubow S. Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3T3-L1 adipose cells. Mol Nutr Food Res. 2006;50:739-45.
14. Onderoglu S, Sozer S, Erbil KM, Ortac R, Lermioglu F. The evaluation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats. J Pharm Pharmacol. 1999;51:1305-12.
15. Wang JG, Anderson RA, Graham 3rd GM, Chu MC, Sauer MV, Guarnaccia MM, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88:240-3.
16. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36:340-4.
17. Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, Loon LJ van. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977-80.
18. Altschuler JA, Casella SJ, Mackenzie TA, Curtis KM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care. 2007;30:813-6.
19. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004;36:119-25.
20. Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of cinnamomum cassia and cinnamomum zeylanicum in vivo and in vitro. Phytother Res. 2005;19:203-6.
21. Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol. 2006;104:119-23.
22. Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J. 2006;47:858-63.
23. Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde - a potential antidiabetic agent. Phytomedicine. 2007;14:15-22.
24. Preuss HG, Echard B, Polansky MM, Anderson R. Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr. 2006;25:144-50.
25. Kwon KB, Kim EK, Jeong ES, Lee YH, Lee YR, Park JW, et al. Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaB. World J Gastroenterol. 2006;12:4331-7.
26. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome [Cochrane review]. Cochrane Database Syst Rev. 2003;(3):CD003053.
27. Hoult JR, Payá M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol. 1996;27:713-22.
28. Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules. 2004;5:798-813.
29. Corex cinnamoni. WHO monographs on selected medicinal plants. Genève: World Health Organisation; 1999. p. 95-104.
30. Hartmann K, Hunzelmann N. Allergic contact dermatitis from cinnamon as an odour-neutralizing agent in shoe insoles. Contact Dermatitis. 2004;50:253-4.
31. Maralhas A, Monteiro A, Martins C, Kranendonk M, Laires A, Rueff J, et al. Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol. Mutagenesis. 2006;21:199-204.
32. Westra WH, McMurray JS, Califano J, Flint PW, Corio RL. Squamous cell carcinoma of the tongue associated with cinnamon gum use: a case report. Head Neck. 1998;20:430-3.
33. Mantovani A, Stazi AV, Macri C, Ricciardi C, Piccioni A, Badellino E. Pre-natal (segment II) toxicity study of cinnamic aldehyde in the Sprague-Dawley rat. Food Chem Toxicol. 1989;12:781-6.
34. Rutten GE, Grauw WJ de, Nijpels G, Goudswaard AN, Uitewaal PJ, Does FE van der, et al. NHG-standaard Diabetes mellitus type 2. Huisarts Wet. 2006;49:137-52.
35. Kleefstra N, Bilo HJ, Bakker SJ, Houweling ST. Chroom en insuline-resistentie. Ned Tijdschr Geneeskd. 2004;148:217-20.
36. Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de Jong B, et al. Chromium treatment has no effect in patients with type 2 diabetes in a Western population. A randomized, double-blind, placebo-controlled trial. Diabetes Care. 2007;30:1092-6.